PR NEWSWIRE - Contenuti promozionali

immediapress comunicato stampa

CHINT Showcased Advanced Power Solutions at CIGRE 2026

PARIS, Aug. 31, 2026 /PRNewswire/ -- As Europe's power grids evolve to accommodate renewable energy, electrification and rapidly growing electricity demand, CHINT, a trusted provider of integrated power and energy solutions, showcased its latest power solutions at CIGRE 2026, highlighting how advance...

immediapress comunicato stampa

Global Tier-1 YFORE Rolls Off First U.S.-Built Digital Key

SUWANEE, Ga., Aug. 28, 2026 /PRNewswire/ -- YFORE Technology officially rolled off its first U.S.-manufactured Digital Key today at its facility in Suwanee, Georgia, marking the start of localized mass production for North America. Utilizing an integrated "Vehicle-Cloud-Device" end-to-end architectur...

immediapress comunicato stampa

La Food and Drug Administration statunitense ha accettato la domanda di autorizzazione per un nuovo farmaco denominato "K-911", destinato a pazienti affetti da glaucoma e ipertensione oculare

NAGOYA, Giappone, 28 agosto 2026 /PRNewswire/ -- Kowa Company, Ltd. (di seguito "Kowa") sta sviluppando K-911 per l'indicazione della riduzione della pressione intraoculare (IOP) nei pazienti con glaucoma o ipertensione oculare tramite la sua società affiliata impegnata nello sviluppo farmaceutico ne...

immediapress comunicato stampa

/C O R R E C T I O N -- Bridge to Life, Ltd./

In the news release, UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life's VitaSmart™ Hypothermic Oxygenated Perfusion System, issued 27-Aug-2026 by Bridge to Life, Ltd. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected releas...



SEGUICI SUI SOCIAL

threads whatsapp linkedin twitter youtube facebook instagram

ora in
Prima pagina
articoli
in Evidenza